Skip to main navigation Skip to search Skip to main content

AAPT Diagnostic Criteria for Chronic Low Back Pain

  • John D. Markman
  • , Katarzyna Czerniecka-Foxx
  • , Partap S. Khalsa
  • , Salim Michel Hayek
  • , Anthony L. Asher
  • , John D. Loeser
  • , Roger Chou

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Chronic low back pain (CLBP) conditions are highly prevalent and constitute the leading cause of disability worldwide. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks (ACTTION) public-private partnership with the US Food and Drug Administration and the American Pain Society (APS), have combined to create the ACTTION-APS Pain Taxonomy (AAPT). The AAPT initiative convened a working group to develop diagnostic criteria for CLBP. The working group identified 3 distinct low back pain conditions which result in a vast public health burden across the lifespan. This article focuses on: 1) the axial predominant syndrome of chronic musculoskeletal low back pain, 2) the lateralized, distally-radiating syndrome of chronic lumbosacral radicular pain 3) and neurogenic claudication associated with lumbar spinal stenosis. This classification of CLBP is organized according to the AAPT multidimensional framework, specifically 1) core diagnostic criteria; 2) common features; 3) common medical and psychiatric comorbidities; 4) neurobiological, psychosocial, and functional consequences; and 5) putative neurobiological and psychosocial mechanisms, risk factors, and protective factors. Perspective: An evidence-based classification of CLBP conditions was constructed for the AAPT initiative. This multidimensional diagnostic framework includes: 1) core diagnostic criteria; 2) common features; 3) medical and psychiatric comorbidities; 4) neurobiological, psychosocial, and functional consequences; and 5) putative neurobiological and psychosocial mechanisms, risk factors, and protective factors.

    Original languageEnglish (US)
    Pages (from-to)1138-1148
    Number of pages11
    JournalJournal of Pain
    Volume21
    Issue number11-12
    DOIs
    StatePublished - Nov 1 2020

    Funding

    We thank Maria E. Frazer, BS, CCRC, for her manuscript production support. Disclosures: The views expressed in this article are those of the authors, none of whom has financial conflicts of interest relevant to the issues discussed in this manuscript. No official endorsement by the US Food and Drug Administration (FDA) should be inferred. Support was provided by the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with the FDA, which has received contracts, grants, and other revenue for its activities from the FDA, multiple pharmaceutical and device companies, and other sources. A complete list of current ACTTION sponsors is available at: http://www.acttion.org/partners.

    Funders
    U.S. Food and Drug Administration
    Food and Drug Administration

      Keywords

      • Chronic low back pain
      • diagnostic criteria
      • lumbar spinal stenosis
      • neurogenic claudication
      • radicular back pain
      • sciatica

      ASJC Scopus subject areas

      • Neurology
      • Clinical Neurology
      • Anesthesiology and Pain Medicine

      Fingerprint

      Dive into the research topics of 'AAPT Diagnostic Criteria for Chronic Low Back Pain'. Together they form a unique fingerprint.

      Cite this